Evidence map›Paper›PMID 26759026›Full record

ReviewJapanese journal of radiology2016

18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations.

Krishan Kant Agarwal, Rachna Seth, Abhishek Behra, Manisha Jana, Rakesh Kumar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Japanese journal of radiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. [European journal of nuclear medicine and molecular imaging · 2025
    Article
  2. Article
  3. Isolated Scapular Lesion of Langerhans Cell Histiocytosis Detected byMolecular imaging and radionuclide therapy · 2022
    Article
  4. Role ofQuantitative imaging in medicine and surgery · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Krishan Kant AgarwalDiagnostic Nuclear Medicine Division, Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India.
Rachna SethDepartment of Paediatrics, All India Institute of Medical Sciences, New Delhi, India.
Abhishek BehraDiagnostic Nuclear Medicine Division, Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India.
Manisha JanaDepartment of Radiology, All India Institute of Medical Sciences, New Delhi, India.
Rakesh KumarDiagnostic Nuclear Medicine Division, Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India. rkphulia@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this article is to provide an illustrative tutorial highlighting the utility of 18F-FDG PET/CT imaging to detect the spectrum of manifestations in patients with Langerhans cell histiocytosis. FDG PET/CT is a powerful tool for making an early diagnosis; it allows higher diagnostic confidence with regard to lesions, measuring the extent of disease (staging) and assessing disease activity, and is consequently useful for evaluating the response to therapy in patients with Langerhans cell histiocytosis.

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyRadiopharmaceuticalsHistiocytosis, Langerhans-CellHumansFluorodeoxyglucose F18RadiopharmaceuticalsFDG PET/CTLangerhans cell histiocytosisPET/CT

Identifiers

PMID26759026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.